Stavroula Sofou

1.6k total citations
49 papers, 1.3k citations indexed

About

Stavroula Sofou is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stavroula Sofou has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Biomaterials and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stavroula Sofou's work include Nanoparticle-Based Drug Delivery (23 papers), RNA Interference and Gene Delivery (20 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Stavroula Sofou is often cited by papers focused on Nanoparticle-Based Drug Delivery (23 papers), RNA Interference and Gene Delivery (20 papers) and Radiopharmaceutical Chemistry and Applications (18 papers). Stavroula Sofou collaborates with scholars based in United States, Russia and Germany. Stavroula Sofou's co-authors include Amey Bandekar, George Sgouros, Michael R. McDevitt, George Sgouros, Shrirang Karve, Charles Zhu, David A. Scheinberg, Frank Bruchertseifer, Aliyah Morgenstern and Jonathan Seideman and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Stavroula Sofou

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stavroula Sofou United States 21 518 487 463 310 259 49 1.3k
Anders E. Hansen Denmark 23 427 0.8× 413 0.8× 539 1.2× 546 1.8× 305 1.2× 61 1.4k
Wouter H. P. Driessen United States 18 242 0.5× 337 0.7× 151 0.3× 509 1.6× 223 0.9× 35 1.1k
Anton Bunschoten Netherlands 19 291 0.6× 353 0.7× 119 0.3× 307 1.0× 139 0.5× 45 1.1k
Clara Santos‐Cuevas Mexico 24 841 1.6× 375 0.8× 346 0.7× 337 1.1× 469 1.8× 85 1.6k
Sandrine Dufort France 27 248 0.5× 651 1.3× 749 1.6× 805 2.6× 566 2.2× 40 2.0k
Masazumi Eriguchi Japan 22 358 0.7× 608 1.2× 404 0.9× 273 0.9× 163 0.6× 83 1.9k
Michael Dunne Canada 19 116 0.2× 415 0.9× 691 1.5× 695 2.2× 176 0.7× 31 1.5k
Luděk Šefc Czechia 17 109 0.2× 289 0.6× 183 0.4× 327 1.1× 152 0.6× 86 1.2k
Niladri Chattopadhyay Canada 13 259 0.5× 380 0.8× 329 0.7× 706 2.3× 612 2.4× 16 1.7k
Ann‐Marie Chacko United States 18 188 0.4× 299 0.6× 256 0.6× 221 0.7× 123 0.5× 47 1.0k

Countries citing papers authored by Stavroula Sofou

Since Specialization
Citations

This map shows the geographic impact of Stavroula Sofou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stavroula Sofou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stavroula Sofou more than expected).

Fields of papers citing papers by Stavroula Sofou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stavroula Sofou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stavroula Sofou. The network helps show where Stavroula Sofou may publish in the future.

Co-authorship network of co-authors of Stavroula Sofou

This figure shows the co-authorship network connecting the top 25 collaborators of Stavroula Sofou. A scholar is included among the top collaborators of Stavroula Sofou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stavroula Sofou. Stavroula Sofou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kavousanakis, Michail E., et al.. (2024). Transport cocktails for cancer therapeutics. Physical Review Research. 6(3). 2 indexed citations
4.
Gabrielson, Kathleen L., et al.. (2024). Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers. European Journal of Nuclear Medicine and Molecular Imaging. 51(9). 2649–2662. 3 indexed citations
5.
Katugampola, Sumudu, et al.. (2022). Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 3989–3999. 10 indexed citations
6.
Sofou, Stavroula, et al.. (2021). Daptomycin-Induced Lipid Phases on Model Lipid Bilayers: Effect of Lipid Type and of Lipid Leaflet Order on Membrane Permeability. The Journal of Physical Chemistry B. 125(22). 5775–5785. 12 indexed citations
7.
Josefsson, Anders, et al.. (2021). Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers. Bioengineering & Translational Medicine. 7(2). e10266–e10266. 11 indexed citations
8.
Josefsson, Anders, et al.. (2021). Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases. European Journal of Nuclear Medicine and Molecular Imaging. 48(13). 4246–4258. 19 indexed citations
10.
Li, Jie, Xuewen Du, Hongjian He, et al.. (2018). Kinetic Analysis of Nanostructures Formed by Enzyme-Instructed Intracellular Assemblies against Cancer Cells. ACS Nano. 12(4). 3804–3815. 43 indexed citations
11.
12.
Zhu, Charles, Amey Bandekar, Sangeeta Ray Banerjee, et al.. (2015). Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues. Molecular Cancer Therapeutics. 15(1). 106–113. 28 indexed citations
13.
Sunderram, Jag, Stavroula Sofou, Kubra Kamisoglu, Vassiliki Karantza, & Ioannis P. Androulakis. (2014). Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges. Journal of Translational Medicine. 12(1). 79–79. 45 indexed citations
14.
Bandekar, Amey, Charles Zhu, Rohit Jindal, et al.. (2013). Anti–Prostate-Specific Membrane Antigen Liposomes Loaded with225Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer. Journal of Nuclear Medicine. 55(1). 107–114. 87 indexed citations
15.
Sofou, Stavroula, et al.. (2012). Nanocarriers to Solid Tumors: Considerations on Tumor Penetration and Exposure of Tumor Cells to Therapeutic Agents. Current Pharmaceutical Biotechnology. 13(7). 1306–1316. 12 indexed citations
16.
Bandekar, Amey, et al.. (2012). Masking and Triggered Unmasking of Targeting Ligands on Liposomal Chemotherapy Selectively Suppress Tumor Growthin Vivo. Molecular Pharmaceutics. 10(1). 152–160. 34 indexed citations
17.
18.
Sofou, Stavroula. (2008). Radionuclide carriers for targeting of cancer. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Sofou, Stavroula & George Sgouros. (2008). Antibody-targeted liposomes in cancer therapy and imaging. Expert Opinion on Drug Delivery. 5(2). 189–204. 95 indexed citations
20.
Sofou, Stavroula. (2008). Radionuclide carriers for targeting of cancer. International Journal of Nanomedicine. 3(2). 181–181. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026